Some of the names on the move ahead of the open.» Read More
Stocksskidded Wednesday, despite a rise in durable-goods orders and some earnings beats, as worries about the recovery dragged on the market.
The weak consumer confidence report that hit U.S. stocks on Tuesday is having a lingering effect this Wednesday, with global stock markets falling and stock index futures pointing to another lower open on Wall Street.
At the end of September, we looked at analysts' price targets for the S&P 500 to see which stocks had the greatest expected gains in the months ahead. So far, 3 out of the October 1 top 5 and 6 out of the top 10 are trading to the upside. Here is the current list of 15 stocks expected to pop (and another 15 expected to drop).
Plus, get calls on earnings, retail, health care and more.
Despite what you’ve heard, the public option might not be off the table after all.
When the etymology of the word “chutzpah” is recorded, Karen Ignagni, who heads the American Health Insurance Plans industry group, will surely earn an honorable mention. On the eve of the Senate Finance Committee’s vote to reform health care, AHIP released a report claiming that committee’s legislation will raise premiums on the average family by thousands of dollars.
Every time you turned around on Wall Street Thursday, it seemed Washington was moving the market. Which stocks are are making big moves and why?
With data from ThomsonReuters, we took a look at which stocks have consensus estimates farthest above their stock prices (as of market close on 9/30/09).
Following are the day’s biggest winners and losers. Find out why shares of Nike and Huntington Bancshares popped while Biogen and Saks dropped.
Plus, a play on the cap-and-trade bill.
That's the reason this group recently took such a big a hit, Cramer says.
Plus, get calls on IPOs and more.
Global health care - particularly for poorer nations - has been a focal point at the Clinton Global Initiative since its inception. Whether fighting AIDS, HIV, malaria, tuberculosis or a myriad of other diseases - the commitments made to help the impoverished reach a level of physical health and wellbeing enjoyed by developed nations.
Market uncertainty has left some as to whether to buy in or get out. Where should investors look to gain profits? Jamie Cox, Managing Partner, Harris Financial Group and Christopher Zook, chairman and CIO of CAZ Investments shared their market insights.
Hint: The real story in the sector has nothing to do with President Obama.
Lawrence Glazer, managing director at Mayflower Advisors shared his market insights and told investors where they should be putting their money.
U.S. consumer confidence rebounded in August after back-to-back monthly declines, but will the gains continue to fuel the economy? Robert Loest, portfolio manager at Integrity Growth and Income and Stephen Gallagher, chief U.S. economist at Societe Generale discussed their outlooks for the consumer and the economy.
With so may investors waiting for a pullback, should you play the market short?
As Obama's disapproval rate goes up, so will the companies that he targets.
Plus, get calls on health care and much more.